Covid-19 treatment | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
May 22, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, MAY 22, 2025

Covid-19 treatment

The World Health Organization logo is pictured at the entrance of the WHO building, in Geneva, Switzerland, December 20, 2021. Photo :Reuters
Coronavirus chronicle

WHO recommends two new drugs to treat Covid-19

The extent to which these medicines will save lives depends on how widely available and affordable they are

Photo: Courtesy
Covid-19 in Bangladesh

Beximco Pharma launches oral drug for Covid-19

Bangladesh suffers from an acute shortage of mental health professionals. Photo: Noor A Alam/TBS
Covid-19 in Bangladesh

Tested Covid negative, but complications make them suffer

Photo: Collected
Coronavirus chronicle

Ivermectin: Here's what can happen with this controversial drug

A box of the drug Ivermectine, made by Biogaran, is pictured on the counter of a pharmacy, as the spread of the coronavirus disease (COVID-19) continues, in Paris, France, April 28, 2020. REUTERS/Benoit Tessier
Coronavirus chronicle

Ivermectin: Oklahoma doctor warns against using drug for Covid treatment

Rajshahi Medical College Hospital (RMCH). File Photo: Collected
Covid-19 in Bangladesh

What health facilities can learn from Rajshahi’s main hospital

A box of the drug Ivermectine, made by Biogaran, is pictured on the counter of a pharmacy, as the spread of the coronavirus disease (COVID-19) continues, in Paris, France, April 28, 2020. REUTERS/Benoit Tessier
Coronavirus chronicle

Oxford University explores anti-parasitic drug ivermectin as Covid-19 treatment

Bangladesh to send Remdesivir to India next week
Coronavirus chronicle

Bangladesh to send Remdesivir to India next week

Eli Lilly and Regeneron Pharmaceuticals Inc. are asking the US government to allow emergency use of their antibody drugs, which aim to help the immune system clear the virus. Photo: AP
Coronavirus chronicle

Zydus Cadila seeks nod to repurpose Hepatitis C drug for Covid-19 in India

People get a treatment in the Wieliczka salt mine to deal with respiratory illness in Wieliczka, Poland February 26, 2021. REUTERSTomasz Swierczek
Coronavirus chronicle

Poles go underground for Covid treatment in Unesco-listed salt mine

Fujifilm to restart clinical trial of Avigan to treat Covid-19: Media
Coronavirus chronicle

Fujifilm to restart clinical trial of Avigan to treat Covid-19: Media

The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France, February 1, 2018. Picture taken February 1, 2018. REUTERS/Vincent Kessler
Coronavirus chronicle

Eli Lilly's antibody combination receives FDA emergency use authorization for Covid-19

Photo: Collected
Coronavirus chronicle

US scientists developing nasal spray to prevent Covid-19

  • Show More
  • loading...
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net